Studies, White Papers
  Studies, White Papers, and Articles
   

Lange Victor, Tarwater Janice. Infection risk associated with a closed luer access device.
Submitted for publication
The purpose of this study was to ascertain whether a needleless valve, when microbiologically challenged, can be thereafter decontaminated with 70% IPA and maintain a physical barrier. Valves were challenged for 3 consecutive days, 24 inoculations per day and 24 access per day, 8 of which per static insertions. Download Pdf
 
Eight Day Microbial Challenge of the MaxPlus Positive Flow Connector
The purpose of this study was to microbiologically challenge the MaxPlus valve over an extended 8 day period. The extended microbial challenge test results indicate that, in all cases, the MaxPlus continued to provide a physical barrier to contamination for an eight day period. Download Pdf
 
Comparison of Contamination Rates among Needleless Access Devices in a Simulated Clinical Use - MaxPlus and ICU Clave®.
The MaxPlus and the ICU Medical Clave device were challenged to compare device susceptibility to contamination during multiple activations. Download Pdf
 
The Use of MaxPlus to Assist in the Prevention and Reduction of BSI's: Results from Two Facilities
Infection Control Professionals from 2 major (500 beds, 523 beds) hospitals tracked CLBSI's before and after implementation of the MaxPlus valve to measure the effectiveness of implementing the MaxPlus as tool to assist in CLBSI prevention. Download Pdf
 

Lenhart Cheryl, BSN, HRM. Continued Studies in Preventing Complications of Central Venous Access Devices (CVAD's)
A total of 32 patients with central catheters were studied. The purpose of the study was to determine if a positive pressure device assists in maintaining catheter patency. A total of 316 access attempts utilizing the MaxPlus positive pressure device were documented. There is no question that positive pressure adapters, when used in conjunction with preventative measures, are a major factor in reducing complications with CVAD's. Download Pdf
 
Tarwater Janice, RN. Impact of Positive Pressure versus Simple Valve Needleless Connector on Occlusion in Central Venous Catheters in Children: A Prospective Trial
The study demonstrates that the MaxPlus positive displacement valve reduced occlusion rate by 40%.
Download Pdf
 
 

Flush Clearance Analysis for the MaxPlus
The purposed of this study was to ascertain if the MaxPlus can be completely flushed after aspiration or infusion of blood product. Download Pdf
 
Blood Sampling Hemolysis Study for the MaxPlus
The purpose of this study was to determine if the MaxPlus causes statistically significant hemolysis during blood aspiration. Download Pdf
 
Blood Transfusion Hemolysis Study for the MaxPlus
The purpose of this study was to ascertain if the MaxPlus causes statistically significant hemolysis during blood transfusion through the MaxPlus device. Download Pdf
 
MaxPlus 72 Hour Activation Testing
The purpose of this test was to evaluate the performance of the MaxPlus valves during and after 204 activations, with the administration of various fluids through the valve over a 72 Hour period
Download Pdf
 
 
 
Studies, White Papers
 
 
 
The MaxPlus Needleless Connector
The MaxPlus is the fastest growing needleless connector on the market today. As evidence to its success the MaxPlus is being utilized in a number of facilities who in 2006 were awarded Honor Roll status by the U.S. News and World Report as 'America's Best Hospitals." The nation's top facilities are using the MaxPlus for two main reasons; it significantly lowers Catheter Related Blood Stream infections CRBSIs and catheter line occlusions. Reducing these two complications improves patient outcomes.
more details >>
 
 
 
2007 Medegen, Inc. , all rights reserved.
MaxPlus and Maximus are registered trademarks of Medegen, Inc.